President John Kennedy famously said that a rising tide lifts all boats, and that is looking to be the case in today’s ...
At this time, I would like to welcome everyone to Karyopharm Therapeutics third quarter 2024 financial results conference ...
Pharmaceutical Technology on MSN18h
Syndax agrees funding with Royalty Pharma for Niktimvo US salesSyndax has entered into a synthetic royalty funding agreement with Royalty Pharma, focused on US net sales of Niktimvo.
MaaT Pharma, a late-stage clinical biotech company, reports Third Quarter 2024 financial results and announces management changes.
Myelodysplastic Neoplasms (MDS)” “Hematological Improvement and Other Clinical Benefits of Elritercept as Monotherapy and in Combination with Ruxolitinib in Participants with Myelofibrosis from the ...
The Company's partner, Incyte, is now recruiting patients for a Phase 2, open-label, randomized, multicenter trial of axatilimab in combination with ruxolitinib in patients ≥12 years of age with newly ...
The full abstracts are now available through the ASH conference website. Pursuant to Disc Medicine practice, the clinical ...
Two tragic incidents in Phuket resulted in the drowning deaths of a five year old Chinese boy and a 43 year old British tourist, police confirmed yesterday. Karon Police were notified by Chalong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback